Page last updated: 2024-11-05

troglitazone and Muscle Contraction

troglitazone has been researched along with Muscle Contraction in 2 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Muscle Contraction: A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iida, KT1
Kawakami, Y1
Suzuki, M1
Shimano, H1
Toyoshima, H1
Sone, H1
Shimada, K1
Iwama, Y1
Watanabe, Y1
Mokuno, H1
Kamata, K1
Yamada, N1
Song, J1
Walsh, MF1
Igwe, R1
Ram, JL1
Barazi, M1
Dominguez, LJ1
Sowers, JR1

Other Studies

2 other studies available for troglitazone and Muscle Contraction

ArticleYear
Effect of thiazolidinediones and metformin on LDL oxidation and aortic endothelium relaxation in diabetic GK rats.
    American journal of physiology. Endocrinology and metabolism, 2003, Volume: 284, Issue:6

    Topics: Acetylcholine; Animals; Aorta, Thoracic; Arteriosclerosis; Cholesterol, LDL; Chromans; Diabetes Mell

2003
Troglitazone reduces contraction by inhibition of vascular smooth muscle cell Ca2+ currents and not endothelial nitric oxide production.
    Diabetes, 1997, Volume: 46, Issue:4

    Topics: Analysis of Variance; Animals; Arteries; Calcium Channels; Chromans; Dose-Response Relationship, Dru

1997